Investing.com -- Moderna (NASDAQ: MRNA) shares dropped 13% pre-open on Monday as investors reacted to the weekend news that the U.S. Food and Drug Administration’s (FDA) top vaccine official, Dr.

Researchers at the University of Cologne have found that mRNA-based COVID-19 vaccines have a lasting impact on the innate ...

While AI offers remarkable efficiency, the pharmaceutical industry must address concerns about “black box” predictions – AI ...

The "RNA Analysis Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F" report has been added to ResearchAndMarkets.com's offering.The Global RNA Analysis Market was ...

Why not all African countries should venture into vaccine business ANALYSIS | The African Union has embarked on one of its ...

Supporters say consumers should be protected from unknowingly eating material from novel vaccines, which are similar to COVID ...

Two molecular control factors play a decisive role in what is known as splicing, the cutting and assembly of mature messenger ...

RNA-based therapeutics are gaining traction due to advancements in delivery technologies, despite historical challenges with ...

Cancer refers to a group of complicated diseases which is one of the top two leading causes of death globally. Traditional chemotherapy and radiation ...

We recently published a list of Did Jim Cramer Nail or Miss These 14 Stocks? In this article, we are going to take a look at ...

Cell- and gene-therapy-focused ElevateBio has let go of 17% of staffers as part of the company’s second layoff round since ...

A breakthrough in safely delivering therapeutic DNA to cells could transform treatment for millions suffering from common chronic diseases like heart disease, diabetes, and cancer.